These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 26559543)

  • 21. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.
    Hayashi K; Michiue H; Yamada H; Takata K; Nakayama H; Wei FY; Fujimura A; Tazawa H; Asai A; Ogo N; Miyachi H; Nishiki T; Tomizawa K; Takei K; Matsui H
    Sci Rep; 2016 Mar; 6():23372. PubMed ID: 26988603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytoplasmic TRADD confers a worse prognosis in glioblastoma.
    Chakraborty S; Li L; Tang H; Xie Y; Puliyappadamba VT; Raisanen J; Burma S; Boothman DA; Cochran B; Wu J; Habib AA
    Neoplasia; 2013 Aug; 15(8):888-97. PubMed ID: 23908590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft model.
    Jensen KV; Cseh O; Aman A; Weiss S; Luchman HA
    PLoS One; 2017; 12(12):e0189670. PubMed ID: 29253028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
    Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor channel TRPC6 is a key mediator of Notch-driven glioblastoma growth and invasiveness.
    Chigurupati S; Venkataraman R; Barrera D; Naganathan A; Madan M; Paul L; Pattisapu JV; Kyriazis GA; Sugaya K; Bushnev S; Lathia JD; Rich JN; Chan SL
    Cancer Res; 2010 Jan; 70(1):418-27. PubMed ID: 20028870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRB2 enhances malignancy of glioblastoma via activation of the NF-κB pathway.
    Wang Y; Bao G; Zhang M; Xiang J; Zhou H; Wahafu A; Wu W; Ma X; Huo L; Bai X; Xie W; Liu P; Wang M
    Exp Cell Res; 2022 May; 414(1):113077. PubMed ID: 35219647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDA-9/syntenin is a key regulator of glioma pathogenesis.
    Kegelman TP; Das SK; Hu B; Bacolod MD; Fuller CE; Menezes ME; Emdad L; Dasgupta S; Baldwin AS; Bruce JN; Dent P; Pellecchia M; Sarkar D; Fisher PB
    Neuro Oncol; 2014 Jan; 16(1):50-61. PubMed ID: 24305713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
    Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
    Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
    Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
    Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion.
    Zhao L; Wang Y; Xue Y; Lv W; Zhang Y; He S
    Acta Biochim Biophys Sin (Shanghai); 2015 Nov; 47(11):890-8. PubMed ID: 26390883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.
    Hong L; Ya-Wei L; Hai W; Qiang Z; Jun-Jie L; Huang A; Song-Tao Q; Yun-Tao L
    J Neurooncol; 2016 May; 128(1):35-45. PubMed ID: 26970980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma.
    Ruan J; Lou S; Dai Q; Mao D; Ji J; Sun X
    Neuroreport; 2015 Jan; 26(2):66-73. PubMed ID: 25494473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
    Gupta P; Dixit D; Sen E
    Carcinogenesis; 2013 Feb; 34(2):388-96. PubMed ID: 23125226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1.
    Liu Y; Yan W; Zhang W; Chen L; You G; Bao Z; Wang Y; Wang H; Kang C; Jiang T
    Oncol Rep; 2012 Sep; 28(3):1013-21. PubMed ID: 22766851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.
    Cahill KE; Morshed RA; Yamini B
    Neuro Oncol; 2016 Mar; 18(3):329-39. PubMed ID: 26534766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
    Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
    J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.